| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/28/2004 | EP1440091A1 Nogo receptor homologues and their use |
| 07/28/2004 | EP1440090A2 A synthetic chimeric fusion protein with immuno-therapeutic uses |
| 07/28/2004 | EP1440083A2 Molecules |
| 07/28/2004 | EP1440080A2 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 20750 |
| 07/28/2004 | EP1440073A1 Pde9 inhibitors for treating cardiovascular disorders |
| 07/28/2004 | EP1440072A2 Purine analogs having hsp90-inhibiting activity |
| 07/28/2004 | EP1440062A1 An efficient synthesis of 5-heteroatom-containing-pyrazoles |
| 07/28/2004 | EP1439885A1 Simplified sarcodictyn derivatives as anti-tumor agents |
| 07/28/2004 | EP1439878A2 Method and apparatus for dispensing inhalator medicament |
| 07/28/2004 | EP1439864A2 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/28/2004 | EP1439863A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 07/28/2004 | EP1439859A1 An antineoplastic- dendritic polymer drug delivery system |
| 07/28/2004 | EP1439850A1 Soluble proteins that inhibit cytokine signal transduction pathways |
| 07/28/2004 | EP1439847A1 Method and composition for repairing and promoting regeneration of mucosal tissue in the gastrointestinal tract |
| 07/28/2004 | EP1439843A2 Tetracycline derivatives and methods of use thereof |
| 07/28/2004 | EP1439839A1 A combination comprising combretastatin and anticancer agents |
| 07/28/2004 | EP1439835A2 Medical compositions for intravesical treatment of bladder cancer |
| 07/28/2004 | EP1439823A1 Pharmaceutical formulation comprising (r)-bicalutamide |
| 07/28/2004 | EP1439819A1 Formulation of an erodible, gastic retentive oral dosage form using in vitro disintegration test data |
| 07/28/2004 | EP1439817A1 Composition containing feverfew extract and use thereof |
| 07/28/2004 | EP1401473A4 Transporters comprising spaced arginine moieties |
| 07/28/2004 | EP1389197A4 Two-step conversion of protected taxane ester to paclitaxel |
| 07/28/2004 | EP1372659B1 Substances for use in therapy of diseases that are caused by highly proliferative cells |
| 07/28/2004 | EP1311660A4 METHOD OF SCREENING FOR INHIBITORS OF HUMAN FATTY ACID-CoA LIGASE 4 |
| 07/28/2004 | EP1278536B1 Depletion method of blood plasma ascorbate |
| 07/28/2004 | EP1238095A4 Compositions and methods for caspase-induced apoptosis |
| 07/28/2004 | EP1226244B1 Polypeptides with non-natural primary signalling motifs |
| 07/28/2004 | EP1175445B1 Specific antibodies and antibody fragments for tgfbeta1 |
| 07/28/2004 | EP1051383B1 Hydroxylation activated prodrugs |
| 07/28/2004 | EP1028739B1 Use of protein h as cytostatic agent |
| 07/28/2004 | EP0931065B1 use of NITRIC ESTER DERIVATIVES IN the treatment of URINARY INCONTINENCE |
| 07/28/2004 | EP0927183B1 Spirocyclic metalloprotease inhibitors |
| 07/28/2004 | EP0912741B1 T-cell selective interleukin-4 agonists |
| 07/28/2004 | EP0823895B1 Fatty acid esters as bioactive compounds |
| 07/28/2004 | EP0719332B1 Monocyte macrophage line recombinant cells for gene therapy |
| 07/28/2004 | CN1516700A Substituted 4H-chromenes and analogs as activators ofgasp ases and inducers of apoptosis and use thereof |
| 07/28/2004 | CN1516697A Aromatic dicarboxylic acid derivatives |
| 07/28/2004 | CN1516687A 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 07/28/2004 | CN1516600A Combinatino medicament for treatment of neoplastic diseases |
| 07/28/2004 | CN1516592A Krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancers, diabetes, premenstrual syndrome and transdermal transport |
| 07/28/2004 | CN1515672A Human chemotactic factor beta-8, chemotactic factor beta-1 and macrophage inflammatory protein-4 |
| 07/28/2004 | CN1515590A Erythropoietin conjugate |
| 07/28/2004 | CN1515586A Diisopropoxyphosphorylated dipeptide methyl ester, its preparation and application |
| 07/28/2004 | CN1515571A Phenyl xanthine derivative |
| 07/28/2004 | CN1515565A Sarcandra flavones coumarins total extract, its medicine composition and application |
| 07/28/2004 | CN1515319A Induction of cytotoxic T lymphocyte response |
| 07/28/2004 | CN1515314A Human liver regeneration related protein and its application |
| 07/28/2004 | CN1515310A Turmeria oil extract dripping pill, its preparation method and application |
| 07/28/2004 | CN1515309A Tumor-removing cancer-eliminating powder |
| 07/28/2004 | CN1515307A Medicine for curing hysteromyoma |
| 07/28/2004 | CN1515294A Solid preparation containing extract of three-bristle cudrania and its preparation method |
| 07/28/2004 | CN1515292A Tenderizing and detoxicating health-care cold tea and its preparation method |
| 07/28/2004 | CN1515256A Application of estrogen antagonist and estrogen excitent for inhibiting pathological disease |
| 07/28/2004 | CN1515251A Composition with function of beautifying face and its application |
| 07/28/2004 | CN1515248A Urea derivative used as inosine-5'-dehydrogenase monophosphate inhibitor |
| 07/28/2004 | CN1515246A New preparation of medicine, its preparation and application method |
| 07/28/2004 | CN1515245A Vaccine containing saponin and sterol |
| 07/28/2004 | CN1515244A Protein-stable pharmacological active matter, its preparation and application method |
| 07/28/2004 | CN1159453C Methods for identifying pathogenic markers in sample o normal cells |
| 07/28/2004 | CN1159440C Mutants of Rb and p53 genes and uses thereof |
| 07/28/2004 | CN1159432C Separated strain of Antrodia camphorate, process for preparing its culture medium and its product |
| 07/28/2004 | CN1159337C Steroides sulfatase inhibitors and methos for making and using same |
| 07/28/2004 | CN1159332C Thiophosphoryl amino acid ester compound and its prepn process |
| 07/28/2004 | CN1159330C Anticancer presursor compound containing anthracycle cytotoxins, its preparing process and itd medicine |
| 07/28/2004 | CN1159327C Oligose with anticancer activity used as medicines or health-care products to improve immunity |
| 07/28/2004 | CN1159318C Metal protease inhibitor, preparing process thereof and pharmaceutical composition contg. same |
| 07/28/2004 | CN1159316C Iso-Indolo-indolone compound, their preparation methods and drug compositions comprising the same |
| 07/28/2004 | CN1159315C 4,5-pyrrolo-oxindoles |
| 07/28/2004 | CN1159056C Medicine for treating mastropathy by exteriorly applying to acupoints |
| 07/28/2004 | CN1159031C Tonglinxiaozheng particles for treating carcinoma of urinary bladder and its preparing process |
| 07/28/2004 | CN1159026C Medicine for treating tumor and its preparing process |
| 07/28/2004 | CN1159021C Tibetans medicine for curing cancer of alimentary canal |
| 07/28/2004 | CN1159019C Extractable compounds and method for making and using the same |
| 07/28/2004 | CN1159017C Antimony halide medicine composition for treating leukemia and lymphoma |
| 07/28/2004 | CN1159016C Medicine composition for treating solid tumor by injection |
| 07/28/2004 | CN1159007C Benzimidazole compounds |
| 07/28/2004 | CN1159005C Inhibiting free radical compound resulting in cancer cell transfer |
| 07/27/2004 | US6768012 Process for the preparation of paclitaxel |
| 07/27/2004 | US6767917 Diuretics; cardiovascular, kidney and brain disorder treatment; antitumor, antiallergen, and antiasthmatic agents |
| 07/27/2004 | US6767916 Chalcone coumarins |
| 07/27/2004 | US6767910 Triazolo[4,5-d]pyrimidinyl compounds |
| 07/27/2004 | US6767906 Inhibit p34cdc2/cyclin bcdc13 kinase and protein tyrosine kinase pp60c-src and can be used for treatment of hyperproliferative diseases, for example chemotherapy of tumours or osteoporosis. |
| 07/27/2004 | US6767743 Method and an apparatus for generating shockwave, a method and an apparatus for accelerating particles, an apparatus for delivering drugs, and a method and an apparatus for delivering DNA |
| 07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 07/27/2004 | US6767705 Recombinant expression construct encoding a reporter gene operably linked to a promoter from a gene the expression of which is induced by a retinoid, wherein the promoter does not contain a retinoic acid response elements site |
| 07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
| 07/27/2004 | US6767565 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 07/27/2004 | US6767561 Plant extracts as antiproliferative, viricides and antiparasitic agents |
| 07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
| 07/27/2004 | US6767020 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle |
| 07/27/2004 | CA2320233C Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 07/27/2004 | CA2251197C The use of mmp-13 selective inhibitors for the treatment of osteoarthritis and other mmp-mediated disorders |
| 07/27/2004 | CA2069900C Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
| 07/22/2004 | WO2004061408A2 Use of a non-specific inhibitor of the 5ht2b receptor for the treatment of prostate cancer |
| 07/22/2004 | WO2004061102A1 Cell cycle-controlling protein and utilization thereof |
| 07/22/2004 | WO2004061090A1 Composition capable of activating natural killer cells and process for producing the same, composition containing natural killer cells activated by the former composition and process for producing the same |
| 07/22/2004 | WO2004061089A1 Dendritic cell line |
| 07/22/2004 | WO2004061073A2 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/22/2004 | WO2004060919A1 Agonist antibody against heteroreceptor |
| 07/22/2004 | WO2004060914A1 A human liver regeneration associated protein and the use of it |